Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.
biomarkers
ground-glass opacity (GGO)
lung cancer
surgery
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
07 09 2019
07 09 2019
Historique:
received:
17
08
2019
revised:
27
08
2019
accepted:
05
09
2019
entrez:
11
9
2019
pubmed:
11
9
2019
medline:
28
7
2020
Statut:
epublish
Résumé
Although lung adenocarcinomas (LADs) with ground-glass opacity (GGO; part-solid tumors) have been shown to differ from those without GGO (pure-solid tumors) in clinicopathological features and prognoses, whether programmed death ligand-1 (PD-L1) protein expression differs between these two tumor types is unclear. This study included 124 patients with clinical T1a-c LAD who received pulmonary resections during 2007-2009. The E1L3N antibody was used to stain for PD-L1 in primary LAD specimens. The specimens were considered PD-L1
Identifiants
pubmed: 31500267
pii: biom9090456
doi: 10.3390/biom9090456
pmc: PMC6769535
pii:
doi:
Substances chimiques
B7-H1 Antigen
0
CD274 protein, human
0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Lung Cancer. 2017 Nov;18(6):e375-e383
pubmed: 28385373
J Thorac Oncol. 2017 Feb;12(2):208-222
pubmed: 27913228
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
J Thorac Oncol. 2017 Sep;12(9):1403-1412
pubmed: 28627462
N Engl J Med. 2018 May 24;378(21):1976-1986
pubmed: 29658848
Lung Cancer. 2016 Aug;98:69-75
pubmed: 27393509
Lancet. 2016 Sep 3;388(10048):1012-24
pubmed: 27598681
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Thorac Oncol. 2019 Jun;14(6):968-978
pubmed: 30851441
J Thorac Oncol. 2019 Feb;14(2):265-275
pubmed: 30368010
J Thorac Oncol. 2016 Aug;11(8):1204-1223
pubmed: 27107787
Clin Lung Cancer. 2018 Jan;19(1):e47-e51
pubmed: 28743420
JAMA Oncol. 2017 Aug 1;3(8):1051-1058
pubmed: 28278348
J Thorac Oncol. 2018 Apr;13(4):533-542
pubmed: 29246833
Ann Thorac Surg. 2017 Jul;104(1):313-320
pubmed: 28433219
Ann Thorac Surg. 2019 Jul;108(1):249-255
pubmed: 30876742
Anticancer Res. 2019 May;39(5):2665-2670
pubmed: 31092466